Pharmacokinetics of Levosimendan in Pediatric Intensive Care Units
Condition(s):Acute Heart FailureLast Updated:September 24, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Acute Heart FailureLast Updated:September 24, 2018Unknown status
Condition(s):Amyotrophic Lateral SclerosisLast Updated:November 28, 2017Completed
Condition(s):Levosimendan; Cardiac Surgery; Heart Failure With Reduced Ejection FractionLast Updated:September 1, 2023Recruiting
Condition(s):Heart ArrestLast Updated:July 21, 2023Not yet recruiting
Condition(s):Transesophageal Echocardiography; Acute Respiratory Distress Syndrome; Right Ventricular DysfunctionLast Updated:March 14, 2023Not yet recruiting
Condition(s):Cardiogenic Shock; Extracorporeal Membrane Oxygenation ComplicationLast Updated:February 16, 2023Recruiting
Condition(s):Levosimendan; Cardiac Surgery; Cardiopulmonary BypassLast Updated:January 17, 2023Recruiting
Condition(s):Sub-arachnoid HaemorrhageLast Updated:February 16, 2024Recruiting
Condition(s):Patients Referred for an Isolated or a Combined Surgical Correction of Functional Moderate to Severe TricuspidLast Updated:May 15, 2023Recruiting
Condition(s):Right Heart Failure; Open-heart SurgeryLast Updated:October 20, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.